11/08/2015 7:18 PM IST | Updated 15/07/2016 8:25 AM IST

Delhi Govt Bans Over-The-Counter Sale Of Aspirin, Disprin, Brufen Without Prescription

Fairfax Media via Getty Images

Delhi government today banned over-the-counter sale of non-steroidal anti-inflammatory drugs (NSAIDs) like Aspirin, Disprin, Brufen, Voveran, without medical prescription as the use of these may pose a threat to dengue patients, Health Minister Satyender Jain said.

"NSAIDs drugs (Aspirin, Disprin, Brufen, Voveran, etc.) will be banned for over-the-counter (OTC) sale by chemists. It will be sold only on the basis of prescription by a qualified doctor," Jain said.

According to senior officials, during this season cases of Dengue are on the rise and drugs like Aspirin and Ibuprofen further cause destruction of platelets in human blood. These drugs may add to the haemorrhage symptoms and can cause death in dengue patients, official said. Health department will take action against any retail chemist found flouting this advice.

"Chemists have also been advised to keep the records of stocks of such pain-killer drugs like Aspirin, Ibuprofen and Diclofenac group of medicines. Stringent action will be taken if anyone is found selling medicine without prescription," official said. Health department has also directed all hospitals in the city to procure NS1 Antigen detection kits and also arrange for adequate number of beds during the peak dengue season. In a bid to spread awareness, schoolchildren will be told about the life cycle of the Aedes mosquito, which transmits dengue, and be engaged in dengue-control activities.

Health department has also asked for pictorial pamphlets to be prepared containing Dos and Don'ts, including symptoms described in easily understandable terms, mode of transmission, habits and habitats of mosquitoes. In order to make people aware about seasonal diseases and not to take certain medicines, Government of Delhi, through the Drugs Control Department, has issued an advisory in public interest.

Like Us On Facebook |
Follow Us On Twitter |
Contact HuffPost India

More On This Topic